Halozyme Therapeutics, Inc. (HALO)
62.91
-0.75
(-1.18%)
USD |
NASDAQ |
May 01, 09:35
Halozyme Therapeutics Price : 62.91 for May 1, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 424.64 |
| Johnson & Johnson | 227.96 |
| Eli Lilly & Co. | 975.00 |
| Baxter International, Inc. | 17.74 |
| Glaukos Corp. | 144.32 |
Price Related Metrics
| PE Ratio | 25.25 |
| PS Ratio | 5.527 |
| Price to Book Value | 152.10 |
| Price to Free Cash Flow | 11.98 |
| Earnings Yield | 3.96% |
| Market Cap | 7.424B |
| Operating PE Ratio | 9.456 |
| Normalized PE Ratio | 13.70 |